Number of Shares
3,794.00
Current Holdings Value*
$450,540.00
% of Portfolio
4.93%
Total Estimate Gain
$-179,393.52
% of Total Estimate Gain
-25.01%

Amplify Treatments, Testing and Advancements ETF's Moderna Inc Holding Summary

As of 2024-06-30, Amplify Treatments, Testing and Advancements ETF held 3,794.00 shares of Moderna Inc(MRNA), totaling $450,540.00. This investment constitutes 4.93% of their stock portfolio, and Amplify Treatments, Testing and Advancements ETF now holds 0% of the outstanding Moderna Inc(MRNA) stock.

The initial trade took place in 2024Q1. In addition, there have been 1 sales at an average price of $126.55 for 3,322.00 shares. Based on historical transaction data and MRNA's current price of $30.97, Amplify Treatments, Testing and Advancements ETF's estimated gain on his MRNA holdings is $-179,393.52, reflecting a -25.01% gain to date.

Amplify Treatments, Testing and Advancements ETF MRNA ($30.97) Holding Chart

Amplify Treatments, Testing and Advancements ETF MRNA ($30.97) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1